iPS Cell Bank Management System for Regulatory Compliance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current systems lack a unified management framework for the production, quality assurance, and inventory management of induced pluripotent stem cells (iPS cells), which are essential for regenerative medicine, due to the complexity of adhering to regulatory standards and ensuring the quality and safety of these cells throughout their production, acceptance, storage, and transportation.

Innovation Solution

A comprehensive system for an iPS cell bank is developed, comprising entry management, acceptance management, production process management, and stock management terminals, which facilitate the tracking and decision-making processes for the collection, production, and storage of iPS cells, ensuring adherence to quality standards and regulatory compliance through a network-connected database system.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a unified management system is implemented for iPS cell production and quality assurance, then quality control and regulatory compliance are improved, but system complexity and implementation cost increase

Engineering Contradiction:
Improvequality controlVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The management system is divided into multiple functional terminals including entry management terminal, acceptance management terminal, production process management terminal, and stock management terminal. Each terminal handles specific aspects of iPS cell management, allowing the complex system to be organized into manageable, specialized components that collectively ensure comprehensive quality control.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A network-connected database system serves as an intermediary that integrates data from various terminals and processes. This central database mediates between different management functions, enabling unified quality assurance and regulatory compliance tracking without requiring direct complex interactions between all system components.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If comprehensive data tracking is implemented for donor information and quality test results, then quality assurance is improved, but data management complexity and storage requirements increase

Engineering Contradiction:
Improvequality assuranceVSAvoiddata volume
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The network database serves multiple functions simultaneously: storing donor information, recording quality test results, tracking production processes, and managing inventory data. This multi-functional database reduces the need for separate data storage systems for each type of information, efficiently managing large volumes of diverse data within a unified platform.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If strict quality evaluation protocols are applied to iPS cells, then product quality is improved, but production time and processing cost increase

Engineering Contradiction:
Improveproduct qualityVSAvoidproduction time
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The system performs preliminary data collection and organization during the production process itself, rather than conducting all quality evaluations after production is complete. By pre-organizing donor information, test results, and production data in the network database, the system reduces the time required for final quality assessment and accelerates the overall production timeline while maintaining strict quality standards.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS11521168B2System and method for iPS cell bank using media
Publication Date: 2022.12.06 FANUC LTD
  • US11521168B2 patent drawing
  • US11521168B2 patent drawing
  • US11521168B2 patent drawing

AI summary

A first terminal determines a collection date of a somatic cell based on a desired collection date and a collectable date transmitted by a second medium; and outputs the collection date to a first medium. A second terminal outputs the collectable date to the second medium; and determines an acceptance date based on the collection date transmitted by the first medium and a production period of an iPS cell transmitted by a third medium. A third terminal determines the production period based on the collection date and a producible period, and determines a shipment date based on the production period and stockable location and period transmitted by a fourth medium; and outputs the production period to the third medium. A fourth terminal outputs the stockable location and period to the fourth medium; and determines stock location and period based on the production period and the stockable location and period.